Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · IEX Real-Time Price · USD
8.49
-0.21 (-2.36%)
At close: Jul 19, 2024, 4:00 PM
8.55
+0.07 (0.77%)
Pre-market: Jul 22, 2024, 7:05 AM EDT
Terns Pharmaceuticals Market Cap
Terns Pharmaceuticals has a market cap or net worth of $548.79 million as of July 22, 2024. Its market cap has increased by 17.21% in one year.
Market Cap
548.79M
Enterprise Value
308.56M
1-Year Change
17.21%
Ranking
Category
Stock Price
$8.49
Market Cap Chart
Since the IPO on February 5, 2021, Terns Pharmaceuticals's market cap has increased from $406.10M to $548.79M, an increase of 35.13%. That is a compound annual growth rate of 9.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 548.80M | 36.86% |
| Dec 29, 2023 | 401.00M | 4.73% |
| Dec 30, 2022 | 382.90M | 114.39% |
| Dec 31, 2021 | 178.60M | -56.02% |
| Feb 5, 2021 | 406.10M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alector | 561.92M |
| National Research | 561.83M |
| Mind Medicine (MindMed) | 559.07M |
| Quanterix | 551.09M |
| Castle Biosciences | 549.94M |
| Neurogene | 548.55M |
| LENZ Therapeutics | 547.72M |
| OmniAb | 545.81M |